Skip to content

Insider · CIK 0001880239

NEA 18 Venture Growth Equity, L.P.

directorowner

Files at NEUE (NeueHealth, Inc.). First filing Oct 6, 2025, latest Oct 6, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $23k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
15Weak
NEUEsell 13
NeueHealth, Inc.
$23k
3,355 shares
-0%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 2, 2025NEUE
NeueHealth, Inc.
XIn-the-money exercise
Common Stock
+1,656,789$0.01$17k1,656,789Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
SOpen-market sale
Common Stock
-2,455$6.75$17k1,654,334Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
XIn-the-money exercise
Common Stock
+607,536$0.01$6,0752,261,870Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
SOpen-market sale
Common Stock
-900$6.75$6,0752,260,970Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
MOption exercise
Common Stock
+124,085$0.01$1,2412,385,055Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
FTax withholding
Common Stock
-182$6.75$1,2292,384,873Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
DDisposition to issuer
Common Stock
-2,384,873--0Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
XIn-the-money exercise
Warrant (Right to Buy)derivative
-1,656,789$0.00$00Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
XIn-the-money exercise
Warrant (Right to Buy)derivative
-607,536$0.00$00Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
AGrant or award
Warrant (Right to Buy)derivative
+124,085--124,085Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
MOption exercise
Warrant (Right to Buy)derivative
-124,085$0.00$00Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
DDisposition to issuer
Series A Convertible Perpetual Preferred Stockderivative
-125,000--0Oct 6, 2025
Oct 2, 2025NEUE
NeueHealth, Inc.
DDisposition to issuer
Series B Convertible Perpetual Preferred Stockderivative
-100,000--0Oct 6, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

NEA 18 Venture Growth Equity, L.P.: insider trades and track record | InsiderTell